{"id":"W4403543935","doi":"10.1038/s41409-024-02444-7","title":"Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia","year":2024,"lang":"en","type":"letter","venue":"Bone Marrow Transplantation","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; U.S. Navy; Health Resources and Services Administration; Syndax Pharmaceuticals; Office of Naval Research; Jazz Pharmaceuticals; Genentech; AstraZeneca; National Institutes of Health; U.S. Department of Health and Human Services; Foundation for the National Institutes of Health; Amgen; Gilead Sciences; U.S. Department of Defense","keywords":"Medicine; Myeloid leukemia; Tyrosine kinase; Fms-Like Tyrosine Kinase 3; Cancer research; Tyrosine-kinase inhibitor; Leukemia; Mutation; CD135; Myeloid; Transplantation; Immunology; Internal medicine; Gene; Cancer; Biology; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0008298858,0.00108724,0.001407163,0.001188386,0.0004059917,0.0002116018,0.0004344071,0.001845223,0.0002206349],"category_scores_gemma":[0.00005179001,0.001005771,0.0007459825,0.0007693938,0.0003059117,0.0002827406,0.0000262019,0.003056842,0.0003185729],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001890278,"about_ca_system_score_gemma":0.002378287,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002919129,"about_ca_topic_score_gemma":0.0004983433,"domain_scores_codex":[0.9937909,0.0002484318,0.001302012,0.001567571,0.001622868,0.001468187],"domain_scores_gemma":[0.9975821,0.0004920476,0.0002567099,0.000862863,0.0004664605,0.0003397682],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004289752,0.000104798,0.0001376365,0.01084223,0.002481185,0.02493456,0.003854308,0.00007476184,0.0720889,0.0003373016,0.8780624,0.002792156],"study_design_scores_gemma":[0.0322294,0.003640541,0.003526592,0.009732625,0.03840799,0.02208933,0.0004640794,0.001516077,0.0680372,0.01096384,0.8043593,0.005033045],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"dataset","genre_scores_codex":[0.105525,0.003743373,0.01395993,0.825361,0.002165386,0.01018044,0.03498778,0.001461726,0.002615368],"genre_scores_gemma":[0.08497675,0.00758711,0.04571087,0.3145626,0.02101318,0.007637653,0.4570965,0.002646716,0.0587686],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.5107983,"threshold_uncertainty_score":0.9994506,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02039674235388189,"score_gpt":0.2848752562052676,"score_spread":0.2644785138513857,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}